Screener
TransCode Therapeutics, Inc. RNAZ Q1 2026 Annual earnings
Reported May 15, 2026 · Before market open
EPS-$21.28
Next report
Aug 18, 2026 (In 6 days)Versus estimates
FAQ
- When did TransCode Therapeutics, Inc. report Q1 2026 earnings?
- TransCode Therapeutics, Inc. (RNAZ) reported Q1 2026 earnings on May 15, 2026 before market open.
- What were TransCode Therapeutics, Inc.'s Q1 2026 revenue and EPS?
- TransCode Therapeutics, Inc. reported eps of $-21.28 for Q1 2026.
- How did TransCode Therapeutics, Inc.'s Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 26.6% from $-16.81.
- Where can I find TransCode Therapeutics, Inc.'s Q1 2026 SEC filings?
- You can read the 10-K periodic report (0001104659-26-043810) directly on SEC EDGAR. The filing index links above go to sec.gov.
